Ichinomiya, Japan

Yoshikazu Suzuki


Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1982-2001

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Yoshikazu Suzuki

Introduction

Yoshikazu Suzuki is a prominent inventor based in Ichinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polyprenyl compounds. With a total of 12 patents to his name, Suzuki's work has had a substantial impact on therapeutic agents for immuno-deficiency diseases.

Latest Patents

Among his latest patents are the β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical compositions containing these compounds. One notable patent describes a β,γ-dihydropolyprenyl alcohol derivative that is useful as a prophylactic therapeutic agent for both human and animal immuno-deficiency diseases. This compound is also effective as a prophylactic agent against infectious diseases. The innovative nature of these derivatives highlights Suzuki's commitment to advancing medical science.

Career Highlights

Yoshikazu Suzuki is currently associated with Eisai Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also enhanced the understanding of polyprenyl compounds in medical applications.

Collaborations

Suzuki has collaborated with notable colleagues, including Isao Yamatsu and Takeshi Suzuki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Yoshikazu Suzuki's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for new therapeutic solutions in the medical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…